Visual and quantitative evaluation of [(18)F]FES and [(18)F]FDHT PET in patients with metastatic breast cancer: an interobserver variability study

PURPOSE: Correct identification of tumour receptor status is important for treatment decisions in breast cancer. [(18)F]FES PET and [(18)F]FDHT PET allow non-invasive assessment of the oestrogen (ER) and androgen receptor (AR) status of individual lesions within a patient. Despite standardised analy...

Descripción completa

Detalles Bibliográficos
Autores principales: Mammatas, Lemonitsa H., Venema, Clasina M., Schröder, Carolina P., de Vet, Henrica C. W., van Kruchten, Michel, Glaudemans, Andor W. J. M., Yaqub, Maqsood M., Verheul, Henk M. W., Boven, Epie, van der Vegt, Bert, de Vries, Erik F. J., de Vries, Elisabeth G. E., Hoekstra, Otto S., Hospers, Geke A. P., der Houven van Oordt, C. Willemien Menke-van
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7167394/
https://www.ncbi.nlm.nih.gov/pubmed/32307594
http://dx.doi.org/10.1186/s13550-020-00627-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7167394/
https://www.ncbi.nlm.nih.gov/pubmed/32307594
http://dx.doi.org/10.1186/s13550-020-00627-z

Ejemplares similares